A chemically defined, protein-free medium (designated CFBI 1000, where CFBI = Clayton Foundation Biochemical Institute) that supports human peripheral lymphocyte proliferation has been developed. This medium allows exploration of individual metabolic differences by varying the medium composition as well as providing a base to explore further the mechanisms of lymphocyte activation in a system initially free of added macromolecular species other than mitogen. The peripheral blood lymphocyte is an ideal system for metabolic studies because it is easily obtained, is a primary resting cell that can be activated to proliferate, and presumably reflects both the genetic makeup and biochemical environmental history of the individual at the time the cells were formed.
The effects of alterations in medium upon growth of cells taken directly from an individual subject have been investigated for a number of years in this laboratory as an approach to the individualized assessment of metabolic and nutritional status. The ready availability of lymphocytes from human peripheral blood relative to other cells and their known activation and blastogenesis in culture media containing fetal calf serum led to their selection as potential cells for this work (1, 2) . The primary resting state of the T lymphocyte can be interrupted by the presence of antigen in association with major histocompatability complex or, more commonly in cell culture systems, a mitogen such as phytohemagglutinin (PHA) or Con A (1). The transition from the resting state to proliferation of lymphocyte cells presumably involves the multiple enzymatic processes characteristic of any growing cell; consequently, it would be anticipated that abnormalities or anomalies in nutrient requirements and metabolism of the lymphocytes would reflect conditions existing in cells of other tissues as well. Furthermore, the metabolic condition of lymphocytes may be influenced by biochemical parameters at the time of their formation and may thereby provide information on past cellular environment (3, 4) .
The association of a clinically recognizable disease with deficiencies of a specific nutrient has led, in most instances, to the rapid use of supplements of that nutrient in the medical treatment of the disease (3) . However, deficiencies of many nutrients-e.g., pyridoxine or riboflavin-do not result in a single clinically recognizable disease but rather in a number of different symptoms manifested in different individuals (3) .
Considerable evidence has accumulated for a relationship between metabolic (and nutritional) status and disease states in individuals (3) ; however, the incorporation of such concepts into general clinical practice has not occurred, largely because broadly based methods for assessment of individual metabolic and nutritional status are not presently available.
To provide an adequate assessment of individual requirements, metabolic function must be assessed over a wide range of reactions rather than simply determining the serum or excretion concentrations of the individual nutrients or the degree of coenzyme saturation of a single enzyme.
We report here a simple, easily manipulated, protein-free medium (designated CFBI 1000, where CFBI = Clayton Foundation Biochemical Institute), whose components have been optimized to support the growth of mitogen-activated, human peripheral blood lymphocytes. The components of Ham's MCDB 104 medium without added serum or protein were used as the starting point for development of a medium to support lymphocyte proliferation (5) . The techniques used in the development of this medium were similar to those described by Ham (6) except that minimal concentrations for optimal responses were determined and used in the development of the medium as described previously (2) 
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Medium Composition and Preparation. The composition of CFBI 1000 medium is presented in Table 1 . Tissue culturegrade water for CFBI 1000 medium is prepared from water distilled in a metal still and subsequently passed through a Continental Water Systems activated carbon cartridge and then through a mixed-bed resin (40%o Rohm-Haas IR 120; 60% Rohm-Haas IRA-410 ion-exchangers). Alternately, water was passed through a Nanopure system (Barnstead) with two activated carbon filters, a mixed-bed resin, and a micron filter and was subsequently distilled from glass (Bellco Glass). Deionized, distilled water was heated to boiling and then degassed under a vacuum; this final procedure removes any residual chlorine, which is detrimental to lymphocyte growth in this medium. Conductivity ofthe water was <1 uS. All solutions for CFBI 1000 medium are made by using this tissue culture-grade water.
The preparation ofthe medium is described in detail, as the formulation is sensitive to the order of addition of the various component chemicals. CFBI 1000 medium is prepared from solid materials and a series of sterile stock solutions, which can be sterilized by filtration and stored in aliquots at -200C (except phenol red, MgSO4, and CaCl2 stock solutions are stored at 25QC). The medium (1 liter) is prepared as follows.
Stock solution IA (500 ml) is formulated by dissolving 11.9 g of Hepes, 0.525 g of K2HPO4 (anhydrous), and 7.01 g ofNaCl in 400 ml of tissue culture-grade water. Phenol red (1 ml, 1.24 g/liter) is added and the pH of the solution is adjusted to 7.6 with the required volume of NaOH. All solutions added subsequently must be at approximately neutral pH. MgSO4' 7H20 (5 ml, 49.3 g/liter), 10 ml of a solution of FeSO4 *7H2O (0.278 g/liter) and Na2 EDTA (0.149 g/liter), and 5 ml of antibiotic solution (GIBCO; penicillin, 10,000 units/ml; streptomycin, 10,000 pg/ml; and Fungizone, 25 ug/ml) are added with stirring; the final volume is adjusted to 500 ml with tissue culture-grade water. This solution is sterilized by filtration. Filtered stock solution IA is stable for at least 4 weeks when stored at 4°C. To this mixture glucose (720 mg) is added, followed by addition of 10 ml each of the following stock solutions, which contain 100-fold the medium concentrations: (0) amino acids (except cysteine and glutamine), (ih) glutamine, (iiM) sodium pyruvate and cysteine, (iv) myoinositol and choline chloride, (v) vitamins, and (vw) adenine. Concentrated vitamin solutions are used to make up the 100-fold stock solution. CaCl2 (5 ml, 22.2 g/liter) is added last to prevent precipitation of the Ca2+. The final volume of the solution is brought to 1 liter with tissue culture-grade water, and the medium is sterilized by filtration. Mitogen (2 ml, 1 mg of PHA per ml) is added after sterilization to prevent any protein loss on the filter. CFBI 1000 medium is stored at 4°C and is stable for at least 4 weeks at this temperature.
Washing Buffer. The buffer solution used in the isolation of lymphocytes from whole blood is prepared as follows. Stock solution IA without MgSO4, iron sulfate/EDTA, and antibiotic solution is diluted 1:1 with tissue culture-grade water. To 100 ml of this solution are added 0.25 ml each of the -previously cited stock solutions of MgSO4, iron sulfate/ EDTAj and CaCl2. The washing buffer is sterilized by filtration and stored at 4°C.
Isolation of Lymphocytes. Blood is collected by venipuncture in tubes (Venoject) containing solid sodium heparin. Human lymphocytes are isolated from this peripheral blood by the method of Boyum (7) or by the method of Ferrante and Thong (8) . Briefly, either blood diluted (1:1.4, vol/vol) with phosphate-buffered saline or whole blood is layered onto Histopaque 1077 and centrifuged at 400 x g for 20 min. The lymphocyte layers from these tubes are carefully removed Fig.  1 . Activation occurred within 24-36 hr, and lymphocyte proliferation reached a maximum at 5.5-6 days and then declined over the following period in culture. The decline in growth rate past the maximum was slightly lower in microtiter wells than in tubes. The individual responses in Fig. 1 Response of Lymphocytes to Variation in Mitogen Concentration. Dose-response curves for PHA and Con A in CFBI 1000 medium have been determined for cells from two individuals (Fig. 3) . The PHA used was not highly purified in order to ensure that the dose-response maximum covers a relatively broad range of concentrations. In contrast, the maximum for highly purified Con A is quite sharp, and higher concentrations are inhibitory. The concentration of Con A that elicited maximal response was normally 0.5 ug of mitogen per ml of medium (Fig. 3) . The maximum for PHA varied between 1 and 5 Ag of mitogen per ml of medium.
Inhibition at higher concentrations was less pronounced than with Con A. No major differences in lectin response were noted between plates and tubes. These responses to mitogens are consistent with those reported in the literature for RPMI 1640 and other media used for growth of human peripheral blood lymphocytes (10, 11) . For routine culture, a concentration of 2 ,.g of PHA per ml was utilized.
Variation in Maximal [3H]Thymidine Incorporation Among
Cells from Different Donors. Some individual variation was observed in the maximal amount of radiolabel incorporated into DNA over time (Figs. 3 and 4) . However, in general, more variability was observed between cells from different individuals than in cells from the same person assayed at different times. The histograms in Fig. 4 demonstrate the variability between persons and between assays carried out at times as disparate as 2 years apart. Differences among individuals for a variety of parameters have been observed consistently in these studies: the maximal amount of radiolabel incorporation, the response to added serum, and the dose-response to mitogen and to serum are highly dependent on the individual. No correlation was observed between diminished radiolabel incorporation (e.g., Fig. 4 , individual C) and stimulation by fetal calf serum. This sort of variability in the lymphocyte proliferation system has been widely reported (11) (12) (13) (14) , with differences in the amount of mitogen required for maximal stimulation, in the amount of radiolabel incorporated, and in the time for maximal radiolabel incorporation (15) (16) (17) (18) .
DISCUSSION
CFBI 1000 medium is a buffered solution containing simple compounds and no protein other than mitogen. Only 13 amino acids are required for maximal lymphocyte growth in most subjects. However, we have found that seine and/or glycine are not synthesized in optimal amounts for some individuals (unpublished results), and these two amino acids are accordingly included in the medium for routine applications. The absence of a requirement for added trace metals may derive either from the short-term culture conditions with insufficient multiplication to deplete cellular stores or from impurities present in the components used to formulate the medium. Serum is not utilized in the formulation, and no protein other than mitogen is added. The growth levels achieved in this medium at low lymphocyte concentrations, as monitored by incorporation of [3H]thymidine into DNA, exceed those obtained in RPMI 1640 medium, which contains 10% fetal calf serum. In the CFBI 1000 medium, the addition of fetal calf serum did not significantly alter the extent of radiolabel incorporation, in contrast to RPMI 1640 medium in which serum is essential. Preliminary evidence suggests that levels (and/or ratios) of amino acids are at least one source of significant inhibition in RPMI 1640 medium. The level of iron in CFBI 1000 medium may be another crucial factor.
Recently, several commercially available media for lymphocyte culture, including RPMI 1640 medium, Dulbecco's modified Eagle's medium, Ham's F 12 medium, and Iscove's modification of Dulbecco's medium, have been supplemented with proteins, including transferrin, insulin, albumin, lactoferrin, or mixtures of these proteins, and lipids to replace serum (11, (19) (20) (21) (22) (23) (24) . Growth oflymphocytes from most individuals is unaffected by addition of insulin or transferrin to the CFBI 1000 medium (data not shown). The absence of transferrin stimulation is in contrast to many other systems (25) . Other stimulatory factors described in the literature (e.g., linoleic acid alone or conjugated with fatty acid-free albumin, ethanolamine, or a-mercaptoethanol) had minimal effect on lymphocyte growth response in CFBI 1000 medium (data not shown).
Response of a resting lymphocyte to mitogen includes blastogenesis and subsequent DNA synthesis associated with cellular proliferation. This DNA synthesis is monitored by incorporation of [3H]thymidine into cellular DNA. Aphidicolin, an inhibitor of DNA polymerase, abolished [3H]thymidine incorporation into lymphocytes in CFBI 1000 medium. Aphidicolin does not inhibit DNA repair (9) nor does it affect mitochondrial DNA synthesis (26) . Thus, the incorporation of radiolabel observed in the CFBI 1000 medium Tr reflects de novo DNA synthesis and can therefore be considered a measure of cellular proliferation.
Individual growth responses differ markedly in this system. Roberts (12) noted that in medium containing serum there were significant variations in mitogen-induced proliferation for lymphocytes from different individuals and in cells from the same individual assayed at different times. In the CFBI 1000 medium, less variability in total response over time was observed for the same individual, although marked differences were found between individuals. Mendelsohn et al. (11) also have reported significant person-to-person variation in growth response. The basis for the variability is unknown, although the extent of monocyte presence in the lymphocyte fraction may be a potential source (13, 27) . Experiments are necessary to determine the population size and types of cells proliferating as well as effects of adherent cell depletion on the lymphocyte response in CFBI 1000 medium.
The simplicity of CFBI 1000 medium allows variation in medium in order to study single limiting processes. For example, the omission of serine and glycine does not significantly decrease the growth response observed after 5 days in tube culture for most individuals, provided that the folinic acid concentration is increased about 10-fold in the medium (data not shown). This modified medium provides a system to determine the effectiveness of serine and glycine biosynthesis and their interconversion in different individuals as well as the folic acid and pyridoxine coenzyme status of these biosynthetic pathways (2) . Omission of riboflavin from the medium results in a significant decrease in lymphocyte response, which is quite variable for different individuals but markedly consistent for a single individual's lymphocytes cultured at different times over a period of several weeks. Thus, the medium components can be manipulated in a wide variety of ways to stress specific metabolic pathways to assess these processes in different individuals. A defined medium also has broad application in the study ofthe immune response mediated by the T-lymphocyte population. The effects of the multiple protein factors that modulate the immune response [e.g., neuropeptides (28) and gonadal steroids (29) ] can be more easily assessed in a medium that is free of other protein components.
The availability of a medium that is easily formulated, is readily varied in composition, and is serum-and protein-free provides a useful tool for a broad range of scientific inquiry. The ease of manipulation facilitates both metabolic and immunologic studies, and the high growth response provides a base for investigating both stimulation and inhibition by other factors. The number of applications for such a system is quite large, and the results of using this medium should be of import in a variety of systems.
